Careful Truss, remember his big "discovery" of 320 (one died lol). plus we should remember the 4 in pilot prior to trial start.
So in fact 324 patients in OA alone.
So
1. GvHD P1 (15)
2. MEND (15 est.)
3. DFU (30)
4. OA (324)
5. GvHD P2 (20 est.) as 3 recruited in March in just 3 weeks, and start of trials always slower.
6. Renal (16 to be recruited but cells are already manufactured of course)
Looking around 420 as we speak.
Note: Mesoblast have only done 1 single arm trial in GvHD in over 10 years (54) Children
Cynata will surpass this number by end of year, if not by October in GvHD 15 + 60 (75) Adults
Cynata has officially treated more Adult GvHD patients in proper US trials than Mesoblast.
so agree
"Don't let the truth get in the way of your story though."
- Forums
- ASX - By Stock
- CYP
- Ann: Investor Presentation
Ann: Investor Presentation, page-235
-
- There are more pages in this discussion • 377 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $35.20M |
Open | High | Low | Value | Volume |
20.0¢ | 20.0¢ | 19.5¢ | $1.705K | 8.654K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 12792 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 32500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10018 | 0.195 |
4 | 126276 | 0.190 |
3 | 15055 | 0.180 |
2 | 5997 | 0.175 |
1 | 50000 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 46000 | 1 |
0.210 | 60000 | 1 |
0.220 | 1875 | 1 |
0.240 | 10000 | 1 |
0.255 | 187726 | 1 |
Last trade - 10.02am 30/08/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online